These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37551616)

  • 1. ONX0914 inhibition of immunoproteasome subunit LMP7 ameliorates diabetic cardiomyopathy via restraining endothelial-mesenchymal transition.
    Wang M; Liu Y; Dai L; Zhong X; Zhang W; Xie Y; Zeng H; Wang H
    Clin Sci (Lond); 2023 Aug; 137(16):1297-1309. PubMed ID: 37551616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
    Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
    J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathelicidin-related antimicrobial peptide protects against cardiac fibrosis in diabetic mice heart by regulating endothelial-mesenchymal transition.
    Zheng X; Peng M; Li Y; Wang X; Lu W; Wang X; Shan Y; Li R; Gao L; Qiu C
    Int J Biol Sci; 2019; 15(11):2393-2407. PubMed ID: 31595157
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
    Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
    Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
    [No Abstract]   [Full Text] [Related]  

  • 5. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin attenuates diabetic cardiomyopathy by increasing autophagy of cardiomyocytes via regulation of VEGF-B/GRP78/PERK signaling pathway.
    Zhang S; Tian W; Duan X; Zhang Q; Cao L; Liu C; Li G; Wang Z; Zhang J; Li J; Yang L; Gao Y; Xu Y; Liu J; Yan J; Cui J; Feng L; Liu C; Shen Y; Qi Z
    Cardiovasc Diabetol; 2024 Jan; 23(1):19. PubMed ID: 38195474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRC5 deficiency ameliorates cardiac fibrosis in diabetic cardiomyopathy by regulating EndMT through Smad2/3 signaling pathway.
    Wang B; Wu Y; Ge Z; Zhang X; Yan Y; Xie Y
    Biochem Biophys Res Commun; 2020 Jul; 528(3):545-553. PubMed ID: 32505342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-195-5p Downregulation Inhibits Endothelial Mesenchymal Transition and Myocardial Fibrosis in Diabetic Cardiomyopathy by Targeting Smad7 and Inhibiting Transforming Growth Factor Beta 1-Smads-Snail Pathway.
    Ding H; Yao J; Xie H; Wang C; Chen J; Wei K; Ji Y; Liu L
    Front Physiol; 2021; 12():709123. PubMed ID: 34658906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy.
    Liu X; Mujahid H; Rong B; Lu QH; Zhang W; Li P; Li N; Liang ES; Wang Q; Tang DQ; Li NL; Ji XP; Chen YG; Zhao YX; Zhang MX
    J Cell Mol Med; 2018 Feb; 22(2):808-822. PubMed ID: 29063670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mangiferin alleviates diabetic pulmonary fibrosis in mice via inhibiting endothelial-mesenchymal transition through AMPK/FoxO3/SIRT3 axis.
    Fu TL; Li GR; Li DH; He RY; Liu BH; Xiong R; Xu CZ; Lu ZL; Song CK; Qiu HL; Wang WJ; Zou SS; Yi K; Li N; Geng Q
    Acta Pharmacol Sin; 2024 May; 45(5):1002-1018. PubMed ID: 38225395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation.
    Kalim KW; Basler M; Kirk CJ; Groettrup M
    J Immunol; 2012 Oct; 189(8):4182-93. PubMed ID: 22984077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway.
    Geng H; Guan J
    Biochem Biophys Res Commun; 2017 Sep; 491(2):329-336. PubMed ID: 28733035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement.
    Zheng Z; Ma T; Guo H; Kim KS; Kim KT; Bi L; Zhang Z; Cai L
    J Cell Mol Med; 2019 Aug; 23(8):5771-5781. PubMed ID: 31199069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
    Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
    J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea protects against diabetic cardiomyopathy by inhibiting inflammation and apoptosis.
    Zhou Y; Lu Q
    Biomed Pharmacother; 2022 Sep; 153():113291. PubMed ID: 35717783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoproteasome inhibition prevents progression of castration-resistant prostate cancer.
    Li J; Liu N; Zhou H; Xian P; Song Y; Tang X; Li Y; Basler M
    Br J Cancer; 2023 Mar; 128(7):1377-1390. PubMed ID: 36681728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart.
    Liang C; Gao L; Liu Y; Liu Y; Yao R; Li Y; Xiao L; Wu L; Du B; Huang Z; Zhang Y
    Life Sci; 2019 May; 224():12-22. PubMed ID: 30872181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
    Sun X; Sun Y; Jiang P; Qi G; Chen X
    Biomed Pharmacother; 2020 Apr; 124():109822. PubMed ID: 31958767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy.
    Ni T; Lin N; Lu W; Sun Z; Lin H; Chi J; Guo H
    Cardiovasc Drugs Ther; 2020 Jun; 34(3):291-301. PubMed ID: 32212062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition.
    Chen XY; Lv RJ; Zhang W; Yan YG; Li P; Dong WQ; Liu X; Liang ES; Tian HL; Lu QH; Zhang MX
    Oncotarget; 2016 May; 7(21):31053-66. PubMed ID: 27105518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.